EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The role of sortilin in cardiovascular calcification: mechanisms and therapeutic potential

Yaqing Yao, Sijia Li, Shuangshuang Wang

Frontiers in Cardiovascular Medicine · 10.06.2026 · 13

DOI: 10.3389/fcvm.2026.1805742 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 10.06.2026. Verfasst von Yaqing Yao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Wenling Hospital of Wenzhou Medical University (The First People's Hospital of Wenling), Wenling, Zhejiang, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular calcification is a common pathological feature driving cardiovascular morbidity and mortality. Although traditionally viewed as a passive degenerative process, current evidence demonstrates that calcification is an actively regulated, cell-driven phenomenon involving osteogenic differentiation, inflammation, and metabolic disturbances. Sortilin (encoded by SORT1 ), a multi-ligand intracellular trafficking receptor, has recently emerged as a critical molecular mediator linking metabolic risk factors—such as dyslipidemia, diabetes, hypertension, and chronic kidney disease—to pro-calcific cellular responses. In addition, sortilin also plays a versatile role by directly participating in the regulation of the phenotypic transformation of vascular smooth muscle cells and valve interstitial cells. This review provides a comprehensive synthesis of SORT1 biology in calcification-related risk states, delineates mechanistic insights into its specific roles in vascular and valve tissues, and discusses translational opportunities and challenges for targeting SORT1 in the prevention and treatment of cardiovascular calcification.

Schlagwörter

Stichwörter der Autor:innen

aortic valve calcificationrisk factorssortilintherapeutic targetvascular calcification

Autor:innen und Institutionen

  • Department of Cardiology, Wenling Hospital of Wenzhou Medical University (The First People's Hospital of Wenling), Wenling, Zhejiang, China.
  • Psychology Department, Australian National University, Canberra, ACT, Australia.

Zitieren

APA

Yao, Y., Li, S., & Wang, S. (2026). The role of sortilin in cardiovascular calcification: mechanisms and therapeutic potential. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1805742

Vancouver

Yao Y, Li S, Wang S. The role of sortilin in cardiovascular calcification: mechanisms and therapeutic potential. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1805742

BibTeX
@article{Yao2026,
  author = {Yao, Yaqing and Li, Sijia and Wang, Shuangshuang},
  title = {The role of sortilin in cardiovascular calcification: mechanisms and therapeutic potential},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1805742}
}
Kostenlos starten →